Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases

Journal of Nutritional Biochemistry

Volumn 20, Issue 5, 2009, Pages 321-336

  Lordan, Sinéad ^a   Mackrill, John J ^a   O'Brien, Nora M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Apoptosis; Cholesterol; Oxides; Oxysterols

Indexed keywords

APOPTOSIS INDUCING FACTOR; BIM PROTEIN; CASPASE; CYTOCHROME C; ENDONUCLEASE G; FAS ANTIGEN; FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; OXYSTEROL; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN MCL 1; PROTEIN NOXA; PUMA PROTEIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; B CELL LYMPHOMA; CELL MEMBRANE FLUIDITY; CELL MEMBRANE PERMEABILITY; DEGENERATIVE DISEASE; GENE EXPRESSION; HUMAN; LIPID RAFT; MITOCHONDRION; NONHUMAN; PATHOLOGY; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS INDUCING FACTOR; ATHEROSCLEROSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CHOLESTEROL; ENDODEOXYRIBONUCLEASES; GENE EXPRESSION; HUMANS; HYDROXYCHOLESTEROLS; INHIBITOR OF APOPTOSIS PROTEINS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, DEATH DOMAIN; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63249096864     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.01.001     Document Type: Review

References (139)

1. Massey J.B., and Pownall H.J. Structures of biologically active oxysterols determine their differential effects on phospholipid membranes. Biochemistry 45 (2006) 10747-10758
2. Guardiola F., Codony R., Addis P.B., Rafecas M., and Boatella J. Biological effects of oxysterols: current status. Food Chem Toxicol 34 (1996) 193-211
3. Brown A.J., and Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 142 (1999) 1-28
4. Schroepfer Jr. G.J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80 (2000) 361-554
5. Wang D.Q., and Afdhal N.H. Good cholesterol, bad cholesterol: role of oxysterols in biliary tract diseases. Gastroenterology 121 (2001) 216-218
6. Rozner S., and Garti N. The activity and absorption relationship of cholesterol and phytosterols. Colloids Surf A Physicochem Eng Asp 282-283 (2006) 435-456
7. Nielsen J.H., Olsen C.E., Duedahl C., and Skibsted L.H. Isolation and quantification of cholesterol oxides in dairy products by selected ion monitoring mass spectrometry. J Dairy Res 62 (1995) 101-113
8. Echarte M., Ansorena D., and Astiasaran I. Fatty acid modifications and cholesterol oxidation in pork loin during frying at different temperatures. J Food Prot 64 (2001) 1062-1066
9. Echarte M., Zulet M.A., and Astiasaran I. Oxidation process affecting fatty acids and cholesterol in fried and roasted salmon. J Agric Food Chem 49 (2001) 5662-5667
10. Conchillo A., Ansorena D., and Astiasaran I. Combined effect of cooking (grilling and roasting) and chilling storage (with and without air) on lipid and cholesterol oxidation in chicken breast. J Food Prot 66 (2003) 840-846
11. Hall M.C. The effect of oxysterols, individually and as a representative mixture from food, on in vitro cultured bovine ovarian granulosa cells. Mol Cell Biochem 292 (2006) 1-11
12. Mazalli M.R., and Bragagnolo N. Effect of storage on cholesterol oxide formation and fatty acid alterations in egg powder. J Agric Food Chem 55 (2007) 2743-2748
13. Saldanha T., and Bragagnolo N. Cholesterol oxidation is increased and PUFA decreased by frozen storage and grilling of Atlantic hake fillets (Merluccius hubbsi). Lipids 42 (2007) 671-678
14. Hur S.J., Park G.B., and Joo S.T. Formation of cholesterol oxidation products (COPs) in animal products. Food Control 18 (2007) 939-947
15. Morrissey P.A., and Kiely M. Oxysterols: formation and biological function. In: Fox P.F., and McSweeney P.L.H. (Eds). Advanced diary chemistry. 3rd ed. Lipids vol. 2 (2006), Springer, New York 641-674
16. Addis P.B. Occurrence of lipid oxidation products in foods. Food Chem Toxicol 24 (1986) 1021-1030
17. Hodis H.N., Crawford D.W., and Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 89 (1991) 117-126
18. Freyschuss A., Xiu R.-J., Zhang J., Ying X., Diczfalusy U., Jogestrand T., et al. Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits. Arterioscler Thromb Vasc Biol 17 (1997) 1178-1184
19. Mahfouz M.M., Kawano H., and Kummerow F.A. Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits. Am J Clin Nutr 66 (1997) 1240-1249
20. Yuan Y.V., Kitts D.D., and Godin D.V. Influence of dietary cholesterol and fat source on atherosclerosis in the Japanese quail (Coturnix japonica). Br J Nutr 78 (1997) 993-1014
21. Vine D.F., Mamo J.C.L., Beilin L.J., Mori T.A., and Croft K.D. Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits. J Lipid Res 39 (1998) 1995-2004
22. Rong J.X., Shen L., Chang Y.H., Richters A., Hodis H.N., and Sevanian A. Cholesterol oxidation products induce vascular foam cell lesion formation in hypercholesterolemic New Zealand white rabbits. Arterioscler Thromb Vasc Biol 19 (1999) 2179-2188
23. Meynier A., Lherminier J., Demaison-Meloche J., Ginies C., Grandgirard A., and Demaison L. Effects of dietary oxysterols on coronary arteries in hyperlipidaemic hamsters. Br J Nutr 87 (2002) 447-458
24. Leonarduzzi G., Sottero B., and Poli G. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). J Nutr Biochem 13 (2002) 700-710
25. Edwards P.A., and Ericsson J. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68 (1999) 157-185
26. Russell D.W. Oxysterol biosynthetic enzymes. Biochim Biophys Acta 1529 (2000) 126-135
27. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88 (1991) 1785-1792
28. Arca M., Natoli S., Micheletta F., Riggi S., Di Angelantonio E., Montali A., et al. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med 42 (2007) 698-705
29. Iuliano L., Micheletta F., Natoli S., Ginanni Corradini S., Iappelli M., Elisei W., et al. Measurement of oxysterols and α-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem 312 (2003) 217-223
30. Björkhem I. Do oxysterols control cholesterol homeostasis?. J Clin Invest 110 (2002) 725-730
31. Makishima M. Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci 97 (2005) 177-183
32. Raghow R., Yellaturu C., Deng X., Park E.A., and Elam M.B. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19 (2008) 65-73
33. Hozoji M., Munehira Y., Ikeda Y., Makishima M., Matsuo M., Kioka N., et al. Direct interaction of nuclear receptor LXRbeta with ABCA1 modulates cholesterol efflux. J Biol Chem 283 (2008) 30057-30063
34. Yan D., and Olkkonen V.M. Characteristics of oxysterol binding proteins. Int Rev Cytol 265 (2008) 253-285
35. Yan D., Mäyränpää M.I., Wong J., Perttilä J., Lehto M., Jauhiainen M., et al. OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. J Biol Chem 283 (2008) 332-340
36. Bowden K., and Ridgway N.D. OSBP negatively regulates ABCA1 protein stability. J Biol Chem 283 (2008) 18210-18217
37. Wyles J.P., McMaster C.R., and Ridgway N.D. Vesicle-associated membrane protein-associated protein-A (VAP-A) interacts with the oxysterol-binding protein to modify export from the endoplasmic reticulum. J Biol Chem 277 (2002) 29908-29918
38. Lehto M., Hynynen R., Karjalainen K., Kuismanen E., Hyvärinen K., and Olkkonen V.M. Targeting of OSBP-related protein 3 (ORP3) to endoplasmic reticulum and plasma membrane is controlled by multiple determinants. Exp Cell Res 310 (2005) 445-462
39. Wyles J.P., and Ridgway N.D. VAMP-associated protein-A regulates partitioning of oxysterol-binding protein-related protein-9 between the endoplasmic reticulum and Golgi apparatus. Exp Cell Res 297 (2004) 533-547
40. Johansson M., Rocha N., Zwart W., Jordens I., Janssen L., Kuijl C., et al. Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor betalll spectrin. J Cell Biol 176 (2007) 459-471
41. Wyles J.P., Perry R.J., and Ridgway N.D. Characterization of the sterol-binding domain of oxysterol-binding protein (OSBP)-related protein 4 reveals a novel role in vimentin organization. Exp Cell Res 313 (2007) 1426-1437
42. Lehto M., Mäyränpää M.I., Pellinen T., Ihalmo P., Lehtonen S., Kovanen P.T., et al. The R-Ras interaction partner ORP3 regulates cell adhesion. J Cell Sci 121 (2008) 695-705
43. Massey J.B. Membrane and protein interactions of oxysterols. Curr Opin Lipidol 17 (2006) 296-301
44. Berthier A., Lemaire-Ewing S., Prunet C., Monier S., Athias A., Bessède G., et al. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 11 (2004) 897-905
45. 2+ channel blockers. Neurochem Res 32 (2007) 87-98
46. Li Y., Ge M., Ciani L., Kuriakose G., Westover E.J., Dura M., et al. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J Biol Chem 279 (2004) 37030-37039
47. Subczynski W.K., Hyde J.S., and Kusumi A. Oxygen permeability of phosphatidylcholine-cholesterol membranes. Proc Natl Acad Sci USA 86 (1989) 4474-4478
48. Dumas D., Latger V., Viriot M.L., Blondel W., and Stoltz J.F. Membrane fluidity and oxygen diffusion in cholesterol-enriched endothelial cells. Clin Hemorheol Microcirc 21 (1999) 255-261
49. Valenzuela A., Sanhueza J., and Nieto S. Cholesterol oxidation: health hazard and the role of antioxidants in prevention. Biol Res 36 (2003) 291-302
50. Kölsch H., Lütjohann D., von Bergmann K., and Heun R. The role of 24S-hydroxycholesterol in Alzheimer's disease. J Nutr Health Aging 7 (2003) 37-41
51. Vaya J., and Schipper H.M. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem 102 (2007) 1727-1737
52. Vega G.L., and Weiner M.F. Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. J Mol Neurosci 33 (2007) 51-55
53. Joffre C., Leclère L., Buteau B., Martine L., and Cabaret S. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr Eye Res 32 (2007) 271-280
54. Vejux A., Malvitte L., and Lizard G. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res 41 (2008) 545-556
55. Giovannini C., Scazzocchio B., Varì R., Santangelo C., D'Archivio M., and Masella R. Apoptosis in cancer and atherosclerosis: polyphenol activities. Ann Ist Super Sanita 43 (2007) 406-416
56. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35 (2007) 495-516
57. Maddika S., Ande S.R., Panigrahi S., Paranjothy T., Weglarczyk K., Zuse A., et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 10 (2007) 13-29
58. Panini S.R., and Sinensky M.S. Mechanisms of oxysterol-induced apoptosis. Curr Opin Lipidol 12 (2001) 529-533
59. Curtin J.F., and Cotter T.G. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 15 (2003) 983-992
60. Lee T.-S., and Chau L.-Y. Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol 280 (2001) 709-718
61. Lordan S., Mackrill J.J., and O'Brien N.M. Involvement of Fas signalling in 7β-hydroxycholesterol- and cholesterol-5β,6β-epoxide-induced apoptosis. Int J Toxicol 27 (2008) 279-285
62. Rho M.-C., Kim Y.K., Chang J.S., Lee H.S., Baek J.A., Chung M.Y., et al. 7-Ketocholesterol predisposes human aorta smooth muscle cells to Fas-mediated death. J Mol Cell Cardiol 39 (2005) 823-832
63. Gupta S., and Gollapudi S. Molecular mechanisms of TNF-α-induced apoptosis in aging human T cell subsets. Int J Biochem Cell Biol 37 (2005) 1034-1042
64. Lee H.S., Chang J.S., Baek J.A., Chung M.Y., Lee H.C., Rhim B.Y., et al. TNF-α activates death pathway in human aorta smooth muscle cell in the presence of 7-ketocholesterol. Biochem Biophys Res Commun 333 (2005) 1093-1099
65. Landis M.S., Patel H.V., and Capone J.P. Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-α from human monocytes. J Biol Chem 277 (2002) 4713-4721
66. Lemaire S., Lizard G., Monier S., Miguet C., Gueldry S., Volot F., et al. Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α-, 7β-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett 440 (1998) 434-439
67. Erridge C., Webb D.J., and Spickett C.M. 25-Hydroxycholesterol, 7β-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic Res 41 (2007) 260-266
68. Prunet C., Montange T., Véjux A., Laubriet A., Rohmer J.-F., Riedinger J.-M., et al. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 69 (2006) 359-373
69. Cross T.G., Scheel-Toellner D., Henriquez N.V., Deacon E., Salmon M., and Lord J.M. Serine/threonine protein kinases and apoptosis. Exp Cell Res 256 (2000) 34-41
70. 2+ oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells. Atherosclerosis 153 (2000) 23-35
71. Yoon J.-H., Canbay A.E., Werneburg N.W., Lee S.P., and Gores G.J. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis. Hepatology 39 (2004) 732-738
72. Leonarduzzi G., Gamba P., Sottero B., Kadl A., Robbesyn F., Calogero R.A., et al. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic Biol Med 39 (2005) 1152-1161
73. Palozza P., Serini S., Verdecchia S., Ameruso M., Trombino S., Picci N., et al. Redox regulation of 7-ketocholesterol-induced apoptosis by β-carotene in human macrophages. Free Radic Biol Med 42 (2007) 1579-1590
74. Adamczyk M., Scherrer E., Kupferberg A., Malviya A.N., and Mersel M. Inhibition of p42/p44 mitogen-activated protein kinase by oxysterols in rat astrocyte primary cultures and C6 glioma cell lines. J Neurosci Res 53 (1998) 38-50
75. Berthier A., Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Pais de Barros J.P., et al. 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. FEBS J 272 (2005) 3093-3104
76. Rusiñol A.E., Thewke D., Liu J., Freeman N., Panini S.R., and Sinensky M.S. AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J Biol Chem 279 (2004) 1392-1399
77. Lordan S., O'Neill C., and O'Brien N.M. Effects of apigenin, lycopene and astaxanthin on 7β-hydroxycholesterol-induced apoptosis and Akt phosphorylation in U937 cells. Br J Nutr 100 (2008) 287-296
78. Moog C., Deloulme C., Baudier J., Revel M.O., Bischoff P., Hietter H., et al. Membrane-related oxysterol function: preliminary results on the modification of protein kinase C activity and substrate phosphorylation by 7beta,25-dihydroxycholesterol. Biochimie 73 (1991) 1321-1326
79. Nelson T.J., and Alkon D.L. Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. J Biol Chem 280 (2005) 7377-7387
80. Rosenblat M., and Aviram M. Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 160 (2002) 69-80
81. Kim R., Emi M., Tanabe K., Murakami S., Uchida Y., and Arihiro K. Regulation and interplay of apoptotic and non-apoptotic cell death. J Pathol 208 (2006) 319-326
82. Gogvadze V., Orrenius S., and Zhivotovsky B. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim Biophys Acta 1757 (2006) 639-647
83. Lizard G., Gueldry S., Sordet O., Monier S., Athias A., Miguet C., et al. Glutathione is implied in 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 12 (1998) 1651-1663
84. Lizard G., Miguet C., Bessède G., Monier S., Gueldry S., Néel D., et al. Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occurring during 7-ketocholesterol-induced apoptosis. Free Radic Biol Med 28 (2000) 743-753
85. Miguet C., Monier S., Bettiaeb A., Athias A., Besséde G., Laubriet A., et al. Ceramide generation occurring during 7β-hydroxycholesterol and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ 8 (2001) 83-99
86. waf1 modulates oxysterol-induced apoptosis. Mol Cell Biol 22 (2002) 1981-1992
87. Biasi F., Leonarduzzi G., Vizio B., Zanetti D., Sevanian A., Sottero B., et al. Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. FASEB J 18 (2004) 693-695
88. Seo D.W., Choi H.-S., Lee S.P., and Kuver R. Oxysterols from human bile induce apoptosis of canine gallbladder epithelial cells in monolayer culture. Am J Physiol Gastrointest Liver Physiol 287 (2004) 1247-1256
89. Rimner A., Makdessi S.A., Sweidan H., Wischhusen J., Rabenstein B., Shatat K., et al. Relevance and mechanism of oxysterol stereospecifity in coronary artery disease. Free Radic Biol Med 38 (2005) 535-544
90. Han J.H., Kim Y.J., Han E.S., and Lee C.S. Prevention of 7-ketocholesterol-induced mitochondrial damage and cell death by calmodulin inhibition. Brain Res 1137 (2007) 11-19
91. Roussi S., Gossé F., Aoudé-Werner D., Zhang X., Marchioni E., Geoffroy P., et al. Mitochondrial perturbation, oxidative stress and lysosomal destabilization are involved in 7β-hydroxysitosterol and 7β-hydroxycholesterol triggered apoptosis in human colon cancer cells. Apoptosis 12 (2007) 87-96
92. Ryan L., O'Callaghan Y.C., and O'Brien N.M. The role of the mitochondria in apoptosis induced by 7β-hydroxycholesterol and cholesterol-5β,6β-epoxide. Br J Nutr 94 (2005) 519-525
93. Seye C.I., Knaapen M.W.M., Daret D., Desgranges C., Herman A.G., Kockx M.M., et al. 7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swelling. Cardiovasc Res 64 (2004) 144-153
94. Meynier A., Andre A., Lherminier J., Grandgirard A., and Demaison L. Dietary oxysterols induce in vivo toxicity of coronary endothelial and smooth muscle cells. Eur J Nutr 44 (2005) 393-405
95. Prunet C., Lemaire-Ewing S., Ménétrier F., Néel D., and Lizard G. Activation of caspase-3-dependent and -independent pathways during 7-ketocholesterol- and 7β-hydroxycholesterol-induced cell death: a morphological and biochemical study. J Biochem Mol Toxicol 19 (2005) 311-326
96. Ryan L., O'Callaghan Y.C., and O'Brien N.M. Comparison of the apoptotic processes induced by the oxysterols 7β-hydroxycholesterol and cholesterol-5β,6β-epoxide. Cell Biol Toxicol 20 (2004) 313-323
97. Ghelli A., Porcelli A.M., Zanna C., and Rugolo M. 7-Ketocholesterol and staurosporine induce opposite changes in intracellular pH, associated with distinct types of cell death in ECV304 cells. Arch Biochem Biophys 402 (2002) 208-217
98. Verhagen A.M., and Vaux D.L. Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 7 (2002) 163-166
99. van Gurp M., Festjens N., van Loo G., Saelens X., and Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304 (2003) 487-497
100. Chen J., Mehta J.L., Haider N., Zhang X., Narula J., and Li D. Role of caspases in oxLDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94 (2004) 370-376
101. Li H.-L., Wang A.-B., Zhang R., Wei Y.-S., Chen H.-Z., She Z.-G., et al. A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages. J Cell Physiol 208 (2006) 307-318
102. Lorenzo H.K., and Susin S.A. Mitochondrial effectors in caspase-independent cell death. FEBS Lett 557 (2004) 14-20
103. Vindis C., Elbaz M., Escargueil-Blanc I., Augé N., Heniquez A., Thiers J.-C., et al. Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. Arterioscler Thromb Vasc Biol 25 (2005) 639-645
104. Widlak P., and Garrard W.T. Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J Cell Biochem 94 (2005) 1078-1087
105. Kutuk O., and Basaga H. Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis. Apoptosis 11 (2006) 1661-1675
106. Youle R.J., and Strasser A. The Bcl-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9 (2008) 47-59
107. Willis S.N., and Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17 (2005) 617-625
108. Kuwana T., and Newmeyer D.D. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15 (2003) 691-699
109. 2/M phase in the human monocytic THP-1 cell line. Life Sci 72 (2003) 1389-1399
110. Lordan S., O'Callaghan Y.C., and O'Brien N.M. Death-signaling pathways in human myeloid cells by oxLDL and its cytotoxic components 7β-hydroxycholesterol and cholesterol-5β,6β-epoxide. J Biochem Mol Toxicol 21 (2007) 362-372
111. Nishio E., and Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem Biophys Res Commun 226 (1996) 928-934
112. Ruiz E., Padilla E., Redondo S., Gordillo-Moscoso A., and Tejerina T. Kaempferol inhibits apoptosis in vascular smooth muscle induced by a component of oxidized LDL. Eur J Pharmacol 529 (2006) 79-83
113. Harada K., Ishibashi S., Miyashita T., Osuga J., Yagyu H., Ohashi K., et al. Bcl-2 protein inhibits oxysterol-induced apoptosis through suppressing CPP32-mediated pathway. FEBS Lett 411 (1997) 63-66
114. Lizard G., Lemaire S., Monier S., Gueldry S., Néel D., and Gambert P. Induction of apoptosis and of interleukin-1β secretion by 7β-hydroxycholesterol and 7-ketocholesterol: partial inhibition by Bcl-2 overexpression. FEBS Lett 419 (1997) 276-280
115. Le Goff D., Viville C., and Carreau S. Apoptotic effects of 25-hydroxycholesterol in immature rat Sertoli cells: prevention by 17β-estradiol. Reprod Toxicol 21 (2006) 329-334
116. Reidl S.J., and Salvesen G.S. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8 (2007) 405-413
117. Bao Q., and Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ 14 (2007) 56-65
118. Rupinder S.K., Gurpreet A.K., and Manjeet S. Cell suicide and caspases. Vascul Pharmacol 46 (2007) 383-393
119. Larsson D.A., Baird S., Nyhalah J.D., Yuan X.-M., and Li W. Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. Free Radic Biol Med 41 (2006) 902-910
120. Vejux A., Kahn E., Ménétrier F., Montange T., Lherminier J., Riedinger J.-M., et al. Cytotoxic oxysterols induce caspase-independent myelin figure formation and caspase-dependent polar lipid accumulation. Histochem Cell Biol 127 (2007) 609-624
121. Luthra S., Dong J., Gramajo A.L., Chwa M., Kim D.W., Neekhra A., et al. 7-Ketocholesterol activates caspases-3/7, -8, and -12 in human microvascular endothelial cells in vitro. Microvasc Res 75 (2008) 343-350
122. Roussi S., Winter A., Gosse F., Werner D., Zhang X., Marchioni E., et al. Different apoptotic mechanisms are involved in the antiproliferative effects of 7β-hydroxysitosterol and 7β-hydroxycholesterol in human colon cancer cells. Cell Death Differ 12 (2005) 128-135
123. Ayala-Torres S., Zhou F., and Thompson E.B. Apoptosis induced by oxysterol in CEM cells is associated with negative regulation of c-Myc. Exp Cell Res 246 (1999) 193-202
124. Yang L., and Sinensky M.S. 25-Hydroxycholesterol activates a cytochrome c release-mediated caspase cascade. Biochem Biophys Res Commun 278 (2000) 557-563
125. Colles S.M., Maxson J.M., Carlson S.G., and Chisolm G.M. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc Med 11 (2001) 131-138
126. O'Callaghan Y.C., Woods J.A., and O'Brien N.M. Characteristics of 7β-hydroxycholesterol-induced cell death in a human monocytic blood cell line, U937, and a human hepatoma cell line, HepG2. Toxicol In Vitro 16 (2002) 245-251
127. 2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells. J Lipid Res 38 (1997) 2049-2061
128. Kölsch H., Ludwig M., Lütjohann D., and Rao M.L. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β. J Neural Transm 108 (2001) 475-488
129. Li W., Dalen H., Eaton J.W., and Yuan X.-M. Apoptotic death of cells inflammatory cells in human atheroma. Arterioscler Thromb Vasc Biol 21 (2001) 1124-1130
130. Prunet C., Petit J.M., Ecarnot-Laubriet A., Athias A., Miguet-Alfonsi C., Rohmer J.F., et al. High circulating levels of 7β- and 7α-hydroxycholesterol and presence of apoptotic and oxidative markers in arterial lesions of normocholesterolemic atherosclerotic patients undergoing endarterectomy. Pathol Biol 54 (2006) 22-32
131. Miguet-Alfonsi C., Prunet C., Monier S., Bessède G., Lemaire-Ewing S., Berthier A., et al. Analysis of oxidative processes and of myelin figures formation before and after the loss of mitochondrial transmembrane potential during 7β-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: comparison with various pro-apoptotic chemicals. Biochem Pharmacol 64 (2002) 527-541
132. Ryan L., O'Callaghan Y.C., and O'Brien N.M. Generation of an oxidative stress precedes caspase activation during 7beta-hydroxycholesterol-induced apoptosis in U937 cells. J Biochem Mol Toxicol 18 (2004) 50-59
133. 2+ and inhibited by the calcium channel blocker nifedipine. Metabolism 56 (2007) 357-362
134. Vucic D., and Fairbrother W.J. The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res 13 (2007) 5995-6000
135. Schimmer A.D. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64 (2004) 7183-7190
136. Blanc-Brude O.P., Teissier E., Castier Y., Lesèche G., Bijnens A.-P., Daemen M., et al. IAP survivin regulates atherosclerotic macrophage survival. Arterioscler Thromb Vasc Biol 27 (2007) 901-907
137. Salonen J.T., Nyyssönen K., Salonen R., Porkkala-Sarataho E., Tuomainen T.P., Dicfalusy U., et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 95 (1997) 840-845
138. Ziedén B., Kaminskas A., Kristenson M., Kucinskienê Z., Vessby B., Olsson A.G., et al. Increased plasma 7β-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease. Arterioscler Thromb Vasc Biol 19 (1999) 967-971
139. Yasunobu Y., Hayashi K., Shingu T., Yamagata T., Kajiyama G., and Kambe M. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols. Atherosclerosis 155 (2001) 445-453